Ichor Falls 41% in a Month as Shorts Hold Steady Before the Print

ICHR heads into its Q3 earnings report with the stock deep in freefall, down 41% over the past month and testing ground not seen in this cycle's recovery.

The most striking feature of the setup is how little the short-selling community has moved to press the advantage. Short interest sits at 8.1% of the free float, a meaningful level, but the trend has actually been easing. The position fell 4.5% over the past week to roughly 2.8 million shares. Borrow cost is a near-negligible 0.40%, down 14% on the week, and availability is loose at 2,444%, meaning shares-to-borrow vastly outnumber shares already borrowed. Shorts could add aggressively if they chose to. The fact that they have not suggests the 41% drawdown has already done much of their work. The options market tells a similar story: the put/call ratio of 0.67 is mildly above its 20-day average of 0.61, but only by about 0.77 standard deviations, well within normal range. Positioning looks cautious rather than crowded on either side.

The analyst community is broadly bullish, but the price action has dramatically undercut the consensus. The mean price target from analysts who last updated in August or later points to prices well above the current $36.84 level, implying a recovery thesis that the market is currently rejecting hard. After the last quarterly print in August, ICHR fell 18% on the day and shed nearly 16% over the following five sessions. That reaction echoes the sharpest fear on the bear side: a company whose revenue is tightly tied to wafer fabrication equipment spending, with a concentrated customer base, has little buffer when end-demand disappoints. Bulls counter that new CEO Phil Barros has been actively rebuilding gross margins, and that revenue and margin trajectories are expected to surpass prior peaks by 2027, making the current multiple compression look like a cyclical overshoot. The PE ratio has contracted by roughly 9.8 points over the past 30 days alone, and the EV/EBITDA has eased to 8.1, meaningfully cheaper than it was entering October. Factor scores offer some support to the bull view: forward EPS momentum ranks in the 85th percentile over 90 days, and the analyst recommendation differential scores in the 92nd percentile, reflecting a degree of Street conviction that the share price is not yet sharing. One caution on analyst figures: the consensus was last struck in early August and several target prices, some above $100, were set before the recent collapse. The gap between mean target and current price is too wide to read as a straightforward upside signal; it may simply reflect stale estimates that have not been revised for the new price level.

Retail attention has spiked sharply, with Wikipedia pageview data showing a z-score of 5.7 against ICHR's own 90-day history as of mid-October. That kind of attention spike in a name down 41% in a month often reflects a mix of distressed-stock interest and short-squeeze speculation rather than fundamental conviction. Among close peers, Monday's session was broadly ugly: UCTT fell 9.1%, AMAT dropped 7.5%, and MKSI lost 6.5%, suggesting the sector backdrop into ICHR's print is weak rather than supportive.

Tonight's release will test whether the August earnings shock was a one-off miss or the opening of a deeper deterioration in Ichor's margin and demand trajectory.